Patent ductus arteriosus management and the drift towards therapeutic nihilism–What is the evidence?
K de Waal, R Prasad, M Kluckow - Seminars in Fetal and Neonatal …, 2021 - Elsevier
The published literature on patent ductus arteriosus (PDA) management is challenging to
interpret due to poorly designed trials with high rates of open label treatments …
interpret due to poorly designed trials with high rates of open label treatments …
Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China
Y Deng, H Zhang, Z Zhao, J Du, R Bai… - European journal of …, 2022 - Springer
The purpose of this study is to assess whether duration and size of the arterial duct were
associated with severe respiratory morbidity and mortality in preterm infants. All …
associated with severe respiratory morbidity and mortality in preterm infants. All …
An observational, prospective, multicenter, registry-based cohort study comparing conservative and medical management for patent ductus arteriosus
No consensus has been reached on which patent ductus arteriosus (PDAs) in preterm
infants require treatment and if so, how, and when they should be treated. A prospective …
infants require treatment and if so, how, and when they should be treated. A prospective …
Impact of cerebral oxygen saturation monitoring on short-term neurodevelopmental outcomes in neonates with encephalopathy-a prospective Cohort study
VV Tewari, A Kumar, A Kurup, H Daryani… - Current Pediatric …, 2022 - ingentaconnect.com
Background: Near-infrared spectroscopy (NIRS) has been used for monitoring cerebral
oxygen saturation (rSO2) in neonates. There is a lack of data from low-middle income …
oxygen saturation (rSO2) in neonates. There is a lack of data from low-middle income …
Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants
SB Cervera, S Saeed, TM Luu, A Gorgos… - Journal of …, 2024 - nature.com
Objective Assess if unit-level PDA management correlates with neurodevelopmental
impairment (NDI) at 18–24 months corrected postnatal age (CPA) in extremely preterm …
impairment (NDI) at 18–24 months corrected postnatal age (CPA) in extremely preterm …
Conservative treatment without any intervention compared with other therapeutic strategies for symptomatic patent ductus arteriosus in extremely preterm infants: a …
J Shin, JA Lee, S Oh, EH Lee, BM Choi - Frontiers in Pediatrics, 2021 - frontiersin.org
Objective: Although symptomatic treatment is the most preferred treatment strategy for
proven symptomatic patent ductus arteriosus (PDA), a considerable number of infants only …
proven symptomatic patent ductus arteriosus (PDA), a considerable number of infants only …
Aminoglycosides were associated with higher rates of surgical patent ductus arteriosus closure in preterm infants
J Marissen, H Erdmann, K Böckenholt… - Acta …, 2021 - Wiley Online Library
Aim In animal studies, aminoglycosides induced ductus arteriosus relaxation in a dose‐
dependent fashion. We tested the hypothesis that antibiotic treatment of preterm infants with …
dependent fashion. We tested the hypothesis that antibiotic treatment of preterm infants with …
Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants
Objective Assess if unit-level PDA management correlates with neurodevelopmental
impairment (NDI) at 18–24 months corrected gestational age (cGA) in extremely preterm …
impairment (NDI) at 18–24 months corrected gestational age (cGA) in extremely preterm …
An Observational, Prospective, Multicenter, Registry-Based Cohort Study Comparing Conservative and Medical Management for Patent Ductus Arteriosus
V Bhandari, J Slaughter, EA Jensen… - … of Patent Ductus …, 2021 - books.google.com
Okulu et al. Conservative vs. Medical Management of PDA differences in the rates of late-
onset sepsis, necrotizing enterocolitis (NEC), retinopathy of prematurity, intraventricular …
onset sepsis, necrotizing enterocolitis (NEC), retinopathy of prematurity, intraventricular …